BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yadav BK, Kaur J, Srivastava A, Ralhan R. Effect of Polymorphisms in XRCC1, CCND1 and GSTM1 and Tobacco Exposure as Risk Modifier for Oral Leukoplakia. Int J Biol Markers 2009;24:90-8. [DOI: 10.1177/172460080902400205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 He P, Wei M, Wang Y, Liu Q. Associations Among Glutathione S-Transferase T1, M1, and P1 Polymorphisms and the Risk of Oral Leukoplakia. Genet Test Mol Biomarkers 2016;20:312-21. [PMID: 27152506 DOI: 10.1089/gtmb.2015.0308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Wang J, Zhu C, Mu G, Xiang Q, Cui Y. Association Between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Risk of Oral Leukoplakia: A Meta-analysis. Genet Test Mol Biomarkers 2021;25:781-7. [PMID: 34890281 DOI: 10.1089/gtmb.2021.0105] [Reference Citation Analysis]
3 Oliveira Alves MG, da Silva Miguel N, Ferreira CCP, Alvarenga ER, Tonon BM, de Barros PP, Carta CFL, Paschoal MBN, de Sales Chagas JF, Bandeira CM, Nunes FD, Almeida JD. Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130:298-305. [PMID: 32682592 DOI: 10.1016/j.oooo.2020.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hernández-Arenas YY, Támara-De Ávila JJ, Isaza-Guzmán DM, González-Pérez LV, Tobón-Arroyave SI. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population. J Oral Biosci 2021;63:217-23. [PMID: 33647453 DOI: 10.1016/j.job.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu B, Shen T. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis. Tumor Biol 2014;35:507-12. [DOI: 10.1007/s13277-013-1071-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kumar A, Pant MC, Singh HS, Khandelwal S. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Mutat Res 2012;729:24-34. [PMID: 21945240 DOI: 10.1016/j.mrfmmm.2011.09.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
7 Roszak A, Lianeri M, Jagodzinski PP. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma. Int J Biol Markers 2011;26:216-20. [PMID: 21928248 DOI: 10.5301/JBM.2011.8581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Donís SP, González AP, Alves MGO, do Carmo Carvalho BF, Ferreira CCP, Almeida JD, Iruegas EP, Petronacci CMC, Peñaranda JMS, Sayáns MP. MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:613-8. [PMID: 33734109 DOI: 10.1097/PAI.0000000000000929] [Reference Citation Analysis]